I agree, and there will be a lot of numbers crunched in respect of MSBs costly treatments. I think ARDS will be very compelling and the costs justified, but some of the chronic conditions where the benefits are more marginal may not be so clear cut....
MSB Trading - 2020, page-12885
-
- There are more pages in this discussion • 10,276 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.32 |
Change
0.035(2.72%) |
Mkt cap ! $1.524B | |||
| Open | High | Low | Value | Volume |
| $1.30 | $1.35 | $1.30 | $2.256M | 1.709M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 7625 | $1.32 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.32 | 36357 | 13 |
View Market Depth
| Last trade - 15.23pm 06/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |